X0206 3 2020-10-27 0 0001439725 BIODESIX INC BDSX 0001021412 SCHULER JACK W 2970 WILDERNESS PLACE, SUITE 100 BOULDER CO 80301 1 0 1 0 Series B Preferred Stock Common Stock 245042 I By Jack W. Schuler Living Trust Series B-1 Preferred Stock Common Stock 245041 I By Jack W. Schuler Living Trust Series C Preferred Stock Common Stock 56155 I By Jack W. Schuler Living Trust Series D Preferred Stock Common Stock 522546 I By Jack W. Schuler Living Trust Series E Preferred Stock Common Stock 296476 I By Jack W. Schuler Living Trust Series F Preferred Stock Common Stock 1056921 I By Jack W. Schuler Living Trust Series G Preferred Stock Common Stock 1586846 I By Jack W. Schuler Living Trust Series H Preferred Stock Common Stock 904060 I By Jack W. Schuler Living Trust 3% Convertible Debt due June 2021 2021-06-30 Common Stock 753735 I By Jack W. Schuler Living Trust Stock Options (Right to Buy) 6.83 2029-07-15 Common Stock 35158 D Stock Options (Right to Buy) 6.83 2030-04-14 Common Stock 35158 D Every share of Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, Series G Preferred Stock and Series H Preferred Stock, (collectively, the "Preferred Stock") is convertible into approximately 0.1684664 shares of Issuer Common Stock ("Common Stock") upon the closing of the Issuer's initial public offering ("IPO"). Share numbers give effect to such conversion. The Preferred Stock has no expiration date. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust. Every share of Series B-1 Preferred Stock ("B-1 Preferred Stock") is convertible into approximately 0.196 shares of Common Stock. Share numbers give effect to such conversion. The B-1 Preferred Stock has no expiration date. This Convertible Debt pays interest at 3% per annum and is payable in full upon maturity through the conversion to Series H Preferred Stock at 80% of the original issuance price of $1.15 per share. On or before the maturity date and if the Convertible Debt is unpaid, the outstanding principal and unpaid accrued interest shall be automatically converted into Common Stock at the completion of the IPO. The conversion price will be equal to 80% of the price per share paid for the Common Stock sold in the IPO. The conversion price is $14.40, or 80% of the $18 price per share paid for the Common Stock sold in the IPO. This option vested in 12 successive, equal monthly installments measured from April 1, 2019. This option vests in 12 successive, equal monthly installments measured from April 1, 2020. Exhibit List Exhibit 24 - Power of Attorney. This Form 3 does not include securities held by the Tino Hans Schuler Trust, Tanya Eva Schuler Trust, Therese Heidi Schuler Trust, Schuler Grandchildren LLC, Schuler Descendants Trust or JS Grandchildren Trust, because the Reporting Person has no pecuniary interest, as such term is used for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, in such securities. /s/ Robin H. Cowie as Attorney-in-Fact for Jack Schuler 2020-10-27